A promising TB vaccine can be protected from heat damage with a technique developed at the University of Bath.
Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.
Their method prevents these crucial vaccine components from spoiling outside of a fridge – meaning a thermally stable vaccine that can be reliably delivered to remote areas around the world is more likely.
There is an urgent need not only for a new TB vaccine, but also for methods to keep vaccines stable outside of the refrigeration ‘cold chain’ – as up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. Thermostable vaccines have therefore been named a priority research area in the World Health Organisation’s Global Vaccine Action Plan 2011-2020.
Ensilication, a method developed at the University of Bath, “shrink-wraps” vaccine proteins in position using layers of silica that build up into a cage around the molecules – so they don’t unravel when exposed to temperatures that would usually break them down. The proteins are held in place until ready to be removed from the silica cage and delivered.
The research team from the Departments of Biology & Biochemistry and Chemistry first demonstrated that the TB antigen ag85b and a vaccine fused with the adjuvant protein Sbi are sensitive to breaking down outside of refrigerated temperatures. They then showed that these vaccine components were protected from heat damage when ensilicated and kept on a shelf at room temperature for long periods of time without loss of structure and function.
This is first time that ensilication has been used to improve the thermal stability of proteins in a vaccine setting, after proof-of-principle work using model proteins.
The results are a big step forward not only in developing a thermally-stable TB vaccines, but in showing that ensilication could be used for many different kinds of vaccines.
The study is published in Scientific Reports
Lead author Professor Jean van den Elsen, said: “A new TB vaccine is really urgently needed to supplement or replace the existing BCG vaccine and reduce the number of TB cases and deaths – particularly as drug-resistant TB infections remain high.”
First author Ayla Wahid, added: “To make the vaccine as effective as possible it needs to be thermally-stable, or in other words not spoil outside of a fridge, which is why we’re really encouraged by these results. Cold-chain storage leads to a lot of wastage and expense which could be avoided by ensilication.”
Dr Asel Sartbaeva, who invented ensilication, added: “Our results reveal the potential of ensilication in storing and transporting life-saving vaccines at ambient temperatures globally – in particular to remote areas of developing countries where disease rates are often highest.
“With up to 50% of vaccines being thrown away, and refrigeration raising vaccine costs by up to 80%, this is a major global health challenge that we need to overcome. By demonstrating for the first time that ensilication works to protect vaccine-relevant proteins from breaking down outside a fridge we’re a big step closer to achieving this goal.”
The Latest on: TB vaccine
[google_news title=”” keyword=”TB vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: TB vaccine
- Record year for badger vaccinations as trailblazing farmers hailed for successon November 26, 2022 at 11:00 pm
Over 250 badgers have been vaccinated against Bovine TB (bTB) in Cornwall this year, making it the most successful season to date.
- ‘UAVs can play vital role in India's TB war’on November 25, 2022 at 10:36 am
Unmanned Aerial Vehicles (UAVs) or drones, which were deployed to deliver Covid-19 vaccines to access compromised areas and strengthen the vaccine delivery system, can play a vital role in India's ...
- Farmer attitudes to bovine TB vaccination mixed, study findson November 25, 2022 at 6:48 am
Farmers are unwilling to take part in badger vaccination strategies to control bovine TB, a new study has found. The negative attitude was revealed during ...
- Record number of badgers vaccinatedon November 24, 2022 at 10:07 pm
A record number of badgers has been vaccinated against bovine tuberculosis (bTB) this year, according to the Cornwall Wildlife Trust (CWT).A total of 251 badgers have been vaccinated in Cornwall so ...
- Record number of badgers vaccinated in Cornwallon November 24, 2022 at 10:07 pm
A total of 251 badgers have been vaccinated in Cornwall so far in 2022. The trust, working with farmers and the Zoological Society of London (ZSL), hopes to expand the programme across more of ...
- Adult Bovine Serum Market to Cross US$ 185.1 Mn at a CAGR value of 5.6% by 2030 | Thermo Fisher Scientific, Auckland BioSciences Ltd.on November 23, 2022 at 5:23 am
Adult bovine serum (ABS) is used in the manufacture of vaccines, and several governments, non-profit organisations, and industry participants, including GlaxoSmithKline plc., are engaging in projects ...
- $5 million from US to boost COVID vaccine rollouton November 22, 2022 at 5:30 am
The United States will provide an additional $5 million in funds in support for the COVID-19 vaccine rollout in the Philippines, US second gentleman Douglas Emhoff said on ...
- Commentary: Why are there tuberculosis cases in Singapore when most have taken the BCG jab?on November 18, 2022 at 10:00 pm
Some may wonder why cases of TB continue popping up in a country with good public hygiene and healthcare. After all, BCG (Bacillus Calmette Guerin) vaccination started in Singapore in the mid ...
- Cooperation in vaccine development between China and Indonesia to expand and deepenon November 16, 2022 at 6:01 pm
The Global Times learned that the content of the cooperation including the agreements on the inhaled tuberculosis (TB) vaccine, Meningitis vaccine and the facilities for the construction of virus ...
- Certain TB correlates of protection linked with the likelihood of becoming infected with Mycobacterium tuberculosison November 14, 2022 at 4:00 pm
This study improves understanding of the immune-related factors that drive infection and disease - necessary for an effective TB vaccine that is yet to be developed. The identification of specific ...
via Bing News